17 Oct 2024
Travere Therapeutics and CSL Vifor Annou ...
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT ...
Get access to the latest news, guides, stock and crypto updates, and take your financial portfolio to the next level.